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Regulation and Guidance for Marketing of Food Ingredients from
Biomanufacturing and Policy Suggestions for China
Abstract
The tightening policy of market regulation for food ingredients and novel foods produced by genetically
modified microorganisms has hindered the development of the bio-economy. Here, the comparative
studies have been conducted on the market regulations of food ingredients and novel foods produced by
biomanufacturing in EU, USA, Japan, and China. These countries are all very concerned about the
regulation of food ingredients and novel foods from biomanufacturing, however, they adopt quite different
polices. EU is cautious, USA is positive, and Japan is less cautious. Over the past decades, China has
been tightening the approval of food ingredients and novel foods produced by genetically modified
microorganisms. At present, the whole world is actively responding to the supervision and access of new
food ingredients and foods produced by new technologies. It is suggested that a positive application and
approval path should be established, unified, and simplified for promoting the marketing of new products
in China.
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Abstract: The tightening policy of market regulation for food ingredients and novel foods produced by genetically
modified microorganisms has hindered the development of the bio-economy. Here, the comparative studies have
been conducted on the market regulations of food ingredients and novel foods produced by biomanufacturing in EU,
US, Japan, and China. These countries are all very concerned about the regulation of food ingredients and novel
foods from biomanufacturing. However, they adopt quite different policies. EU is cautious, US is positive, and Japan is less cautious. Over the past decades, China has been tightening the approval of food ingredients and novel
foods produced by genetically modified microorganisms. At present, the whole world is actively responding to the
supervision and access of new food ingredients and foods produced by new technologies. It is suggested that a positive application and approval path should be established, unified, and simplified for promoting the marketing of new
products in China. DOI: 10.16418/j.issn.1000-3045.20200405001-en
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food have been modified or produced with novel biotechnologies, and some have been applied in industrial
production.
With the support of major national research projects such
as National High-tech R&D Program (863 Program), National Basic Research Program of China (973 Program), and
National Key R&D Program of China, extensive studies have
been performed on the application of biotechnology in the
manufacturing of food ingredients. However, some advanced
achievements have been shelved because of inaccessibility to
market and approval. The tightening policy is detrimental to
the development of biomanufacturing in China. As manufacturers have no new technology that can be used in international competition, the industrialization and manufacturing
technology/performance of products in China have lagged
behind those in foreign countries, which seriously hinders the
development of bio-economy in China.
We compared the market regulations of food ingredients
and novel foods produced by biomanufacturing in the EU,
US, Japan, and China, and put forward suggestions for the
access of biomanufacturing in the food industry in China.
For ease of understanding, food ingredients or novel foods
manufactured by microorganisms without genetic modification are referred to as traditional food ingredients (TFIs), and
those manufactured by genetically modified microorganisms
(GMMs) are referred to genetically modified food ingredients
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Green development is one of the five major concepts of
social development in China in the new era. Biomanufacturing, an important way to implement green development, is
listed as a national strategic emerging industry, which has
been booming. The analysis of six developed countries in
Europe and America by the Organization for Economic
Co-operation and Development (OECD) shows that application of biomanufacturing technologies has the potential to
reduce energy consumption by 15%–80%, raw material
consumption by 35%–75%, air pollution by 50%–90%, water
pollution by 33%–80%, and operating costs by 9%–90% in
industrial processes. It is estimated that, by 2030, 35% of
chemicals and related industrial products will be produced by
biomanufacturing, reducing CO2 emissions by 1–2.5 billion
tons per year [1].
In the food industry, biomanufacturing products or technologies based on enzymes and microorganisms have been
widely used to improve the quality of food ingredients,
optimize traditional processing techniques, and reduce
pollutant emissions, which have improved the mode of food
manufacturing. In recent years, the emergence of biotechnologies represented by recombinant DNA, gene editing, and
synthetic biology has laid a solid foundation for the revolution of food industry [2]. Globally, probiotics [3], low-calorie
sweeteners [4], nutritional chemicals, synthesized milk [5],
lab-grown meat [5], and degradable packaging materials for
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(GMFIs). This study aims to help accelerate the marketing of
food ingredients from biomanufacturing and boost their
healthy development in China.

1 Market regulation of biomanufactured food
ingredients in the EU
The EU attaches great importance to the market regulation
of biomanufactured food ingredients and has established a
comprehensive management system after years of development. The European Food Safety Authority (EFSA) supervises and assesses the safety of biomanufactured products as
food additives [6]. The EU adopts different regulation strategies for microorganisms as production tools or raw materials,
providing a clear path for the development and application of
new technologies.

Market regulation of TFIs in EU

1.2

Market regulation of GMFIs in the EU

The EU has a strict definition of GMMs, and the microorganisms produced by DNA recombination with vectors or
techniques involving direct introduction of genetic materials
are recognized as GMMs (presence of exogenous DNA),
while those with DNA modification by transduction, conjugation, polyploid induction, cell fusion, or mutagenesis by
exposure to specific environment are recognized as
non-GMMs (absence of exogenous DNA or genes). The
regulation of technologies is shown in Table 1.
example, amino acids (category I) produced by GMMs
may be exempted from assessment against the above criteria
if the product is refined or purified to contain single component without microbial cells, DNA, and RNA. One representative example of category II GMFIs is food enzyme.
Currently, the EFSA is assessing 216 products [15], and a large
number of them will be marketed in the future.

I

1.1

Regulation (EU) 2015/2283 [8] was released by the European
Commission on December 11, 2015 and came into force on
January 1, 2018.
A microorganism can be used to apply for QPS, or its
fermentation products or biomass can be used to apply for
novel foods. For example, Yarrowia lipolytica is on QPS list
(only for production purpose) [9], and the food made from it
has been approved as a novel food [10].

Regulation of common genetic modification technologies in the EU, US, and Japan [11]
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Table 1

K

In 2003, the EFSA introduced the qualified presumption of
safety (QPS) approach [7], which requires microorganisms to
pass QPS before being used as production tools. In 2007, the
EFSA issued the first QPS list and then released QPS Panel
Statement every six months and new QPS list every three years.
Foods with microorganisms as raw materials are regulated
in the EU under the Regulation (EU) on novel foods. The
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Genetically modified microbial strains that are originally
included in QPS list can be included again if they pass the
safety assessment of EFSA [16,17].
The EU stipulates that all GMFIs on the market should be
labeled regardless of whether DNA or protein from GMMs is
detected in the final products. Moreover, common foods
containing > 0.9% GMFIs should also be labeled. In the case
of exemption, labeling is not mandatory if the food contains
or consists of < 0.9% GMFIs, or if the producer provides
sufficient evidence to the authority indicating the presence of
a single GMFI whose presence is adventitious or technically
unavoidable [22].

2 Market regulation of biomanufactured food
ingredients in the US

Category and relevant laws or guidelines of genetically modified food ingredients (GMFIs) [18]
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Table 2
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The Food and Drug Administration (FDA) is responsible
for the safety management of microorganisms and their
products used in foods. The US adopts a positive attitude
towards the use of GMMs in food industry, and does not
clearly define or distinct between TFIs and GMFIs. Risk
assessment is based on the product itself or the use of the
product rather than the manufacturing process.
FDA established a list of generally recognized as safe
(GRAS) products to regulate food additives. In the US,

GRAS can be determined by (1) FDA approval, which has
not been in practice since 1997 and only exists in the Act; or
(2) self-confirmation, for which FDA has developed a specific procedure and checklist of materials [23,24]. In the
①
USP/FCC Appendix XV of US Pharmacopeia (USP) updated in 2012, official description of the general and special
requirements of food microorganisms, including probiotics,
is provided as a standard reference for enterprises to apply for
GRAS approval by FDA [25,26]. Usually less than six months
are required from application to a GRAS approval by FDA.
In addition to the GRAS list, some biomanufactured products
as food additives are reviewed and approved by FDA’s Office
of Food Additive Safety based on the assessment of consumer safety, chemistry, and toxicology.
Products in the four categories of GMFIs have been approved as GRAS or as food additives for marketing in the US
(Table 3).
In terms of labeling products on the market, the US passed
the Bioengineered Food Disclosure Law in 2016, which was
enacted on January 1, 2020 and will be enforced on January
1, 2022. The law requires labeling of foods containing
GMFIs, but with two exemptions: (1) foods containing
known GMFIs, provided that the total amount of all GMFIs
used in the product is ≤ 5% of the total weight of the product;
and (2) foods served only in restaurants or similar retail food
stores.

______________________________________

① FFC, Food Chemical Codex
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Table 3 Typical cases of food ingredients produced by genetically modified microorganisms and approved as generally recognized as
safe or food additives in the US

3 Market regulation of biomanufactured food
ingredients in Japan

In Japan, most microorganisms used to produce food additives and common foods, along with their products, are
managed through the food additive system. While some
probiotic strains mainly used in the production of specific
health foods are managed through a specific health food
system. In Japan, the Ministry of Health, Labour and Welfare
is responsible for the management of food additives and the
safety approval of genetically modified foods.

3.1

Market regulation of TFIs in Japan

In 1948, the Food Sanitation Law, the first comprehensive
law on food safety/sanitation was enacted in Japan, which
established a positive list system for food additives, and only
food additives designated as safe by the Ministry of Health,
Labour and Welfare can be used. In 1995, the positive list was
expanded from chemically synthesized food additives to the
majority of additives used in foods.
The Food Sanitation Law stipulates that novel food additives apply for approval of marketing by the Ministry of
Health, Labour and Welfare. The Ministry of Health, Labour

and Welfare submit the application materials to the Pharmaceutical Affairs and Food Sanitation Council, which examines the process necessity and function of the additive, and
sets quality specifications and standards for the food additive
based on assessment of impact on health. The Food Safety
Commission in the Cabinet Office of Japan is primarily responsible for risk assessment and establishment of allowable
daily intake. A special investigation team conducts a scientific risk assessment on the food additive, seeks public
comments, and feeds the results back to the Ministry of
Health, Labour and Welfare [30].

3.2

Market regulation of GMFIs in Japan

In Japan, the Guidelines for the Safety Assessment of
Foods and Food Additives Produced with DNA Recombination Techniques was established as early as in 1991 to restrain
the safety review guidelines for genetically modified foods
and food additives, followed by the Inspection Methods for
Foods Produced with DNA Recombination Techniques
(March 27, 2001) and the Law Concerning Standardization
and Proper Labeling of Agricultural and Forestry Products
(April 1, 2001).
On March 25, 2004, the Food Safety Commission of Japan
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Table 4 presents the typical cases of category I, II, and III
GMFIs approved for marketing in Japan. It is believed that
there will be gene-edited category IV GMFIs approved for
marketing with a positive attitude toward gene editing in Japan.
In terms of labeling products on the market in Japan, specific labeling methods have been established for foods with
safety certificate of genetic modification and foods with
residual recombinant DNA or its encoded protein after processing, by the Law Concerning Standardization and Proper
Labeling of Agricultural and Forestry Products, and the terminology used on the labels for foods with TFIs has been
standardized. With the emergence of gene editing technology,
the Consumer Affairs Agency of Japan announced on September 19, 2019 that producers and sellers of most foods
produced by gene editing are not obliged to label them as
gene-edited foods. The eventual implementation of this
guideline may be related to the aforementioned safety approval of gene editing technology.

I

declared the Standards for Safety Assessments of Food Additives from Genetically Modified Microorganisms, in which
DNA recombination technology is defined as that used to
recombine DNA molecules by enzymes or other methods and
to transfer them into living cells for multiplication. Genetically modified additives shall be covered by the additives
approved by the Food Sanitation Law. In principle, if an
exogenous gene is derived from the DNA of a microorganism
belonging to the same taxonomic group as the host, or if a
modified microorganism has the same genetic structure as a
microorganism that already exists in the nature, they are not
recognized as DNA recombination technologies. However, if
the dose-dependent effect of an additive on human health is
unclear, the effect should be examined as required. In addition, the final products with residual microbial cells are required to meet the safety assessment criteria for genetically
modified foods (microorganisms) (Table 1). Meanwhile, the
criteria suggest that the safety assessment of GMFIs should
take into account the level of additive refinement, the way of
use, and the amount of residue in the food. In the Appendix
revised in April 2005, GMMs-produced non-protein additives with highly refined end products (i.e., amino acids and
vitamins) are recognized as safe, and safety assessment based
on these criteria is unnecessary. Therefore, high-purity food
additives (i.e., vitamins, amino acids, and nucleotides) produced with GMMs are equivalent to non-genetically modified food additives in Japan.
Japan is also facing the emergence of new technologies
with a positive attitude. For example, an expert advisory
committee in Japan recommended approval of gene-edited
foods to be sold to consumers without safety assessment, provided that the technologies involved meet certain criteria. The
final report for the implementation of this recommendation has
not been published, while an initial draft was posted on the
website of the Ministry of Health, Labour and Welfare of Japan
on March 18, 2019 for public comment [31].

K

4 Market regulation of biomanufactured food
ingredients in China

CN

According to Article 37 of the Food Safety Law of the
People’s Republic of China, production of foods with novel
ingredients, production of novel food additives, and production of novel food-related products require submission of
safety assessment documents of the product to the health
administrative department of the State Council. The Ministry
of Health, the National Health and Family Planning Commission (NHFPC), and the National Health Commission
(NHC) have been successively in charge of the review, approval, and supervision of biomanufactured food ingredients,
mainly involving novel food ingredients, food additives, and
the List of Microorganisms for Food Production. GMFI is not
defined and differentially managed in China.

Table 4

Typical cases of genetically modified food ingredients (GMFIs) approved for marketing in Japan

© 2020 China Academic Journals (CD Edition) Electronic Publishing House Co., Ltd.
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4.1

Market regulation of TFIs in China

4.3 Comparison of market regulations of biomanufactured food ingredients in the US, EU, Japan,
and China
By comparison, the EU implements full-process supervision of biomanufactured food ingredients and takes a cautious attitude towards biotechnology, though a large number
of category I products have been approved for marketing
after safety assessment. The US mainly controls the end
products and has a positive attitude towards biotechnology.
Japan has adopted a moderate attitude balancing those of EU
and US. China is currently cautious about marketing of biotechnology products, tightening the approval of GMFIs for
many years, with only a few category II products approved
before and after 2019 (Figure 1).
With the emergence of new biotechnologies, the EU, US,
and Japan have approved many biomanufactured food ingredients for marketing. Highly-productive chassis cells as
well as optimized functional gene elements and metabolic
pathways confer biological production and the products have
high yield, low pollution, and simple production process,
which have greatly impacted traditional industries. In sharp
contrast, some world-leading biomanufacturing technologies
of food ingredients in China have been shelved due to the
absence of market access approval, such as salidroside, lycopene, high value-added products manufactured by genetically engineered enzymes (e.g., allulose, chitosan
oligosaccharide, stevioside RA/RD/RM), glycyrrhizic acid,
glucosamine, and amino acids. Some of these products (e.g.,
sialic acid and rebaudioside M) have been instead submitted
to the US FDA for GRAS.

CN
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The products manufactured by microorganisms and microorganisms as products are mainly regulated in China according to the laws and regulations of novel food ingredients
and additives. For novel food ingredients, the NHFPC issued
in 2013 the Measures for Administration of Safety Review of
Novel Food ingredients, the Regulations on the Application
and Acceptance of Novel Food ingredients, and the Procedures for Safety Review of Novel Food ingredients. From
2008 to 2019, a total of 130 novel food ingredients were
approved, including 23 novel microbial strains. Food additives are listed in the National Standards of Food Safety: Use
of Food Additives (GB 2760-2014), the National Standard of
Food Safety: Use of Food Nutrient Fortifiers (GB
14880-2012), and the announcements of national health administration departments. From 2014 to 2019, a total of 180
novel food additives, 11 novel nutrient fortifiers, and 20
nutrient fortifiers with expanded usage and dosage were
approved.
For the microorganisms used for food production, the
Ministry of Health issued the List of Microorganisms for
Food Production in 2010 and the List of Microorganisms for
Infant Food Production in 2011. Microorganisms traditionally used in food production and processing can be used
without approval, while novel strains out of the lists should
be approved in accordance with the Measures for Administration of New Source Food (from December 1, 2007 to
October 1, 2013) and the Measures for Administration of
Safety Review of Novel Food Ingredients (after October 1,
2013).

GB2760 after approval. There are currently 56 GMFI-derived
enzyme preparations used in food industry. In 2009, the Food
Safety Law of the People’s Republic of China transformed
the approval of novel food additives into administrative licensing, and only one and 13 novel enzyme preparations in
food industry were licensed in 2019 and 2020, respectively.

4.2

Market regulation of GMFIs in China

There is currently no approval of category I, III, and IV
GMFIs in China (Table 2). For category II GMFIs, novel food
enzyme preparations derived from GMFIs were applied as
novel food additives in China before 2009 and included in

Figure 1

Comparison of market regulations of biomanufactured food ingredients in the US, EU, Japan, and China
Dashed lines: inaccessible; solid lines: accessible.
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Therefore, promotion of the marketing approval of biomanufactured food ingredients will greatly advance the
commercialization of biomanufacturing R&D achievements
in China, promote the development of biomanufacturing
industry, and help Chinese enterprises take the lead in the
new round of international competition. This is of strategic
significance for national security, economic growth, and
regional development.

5 Debates on the access of new technologies in
synthetic biology

6 Suggestions on promoting the marketing of
biomanufactured food ingredients in China
China has currently approved some category II GMFIs,
which is temporary and achieved by administrative coordination, because the requirements and processes of technical
review remain at the level of consensus within the ministries
and commissions, and clear institutionalized regulations are
still lacking. There is no application timeline and successful
cases are very limited. Legislation and institutionalization
have seriously lagged behind the development of science and
technology. Based on the above problems, we put forward the
following three suggestions.
(1) Accelerating legislation. We should promote the enactment of Biosafety Law and relevant regulations as soon as
possible, clarify the management requirements for new
technologies and their applications, and define the management responsibilities from the perspective of safety. We
should establish the criteria for R&D, production, and application of biomanufactured products with a positive attitude, clarify the application and review procedures of novel
products, unify market access criteria and review systems,
and simplify review processes to promote the marketing of
novel products, especially the biosafety assessment and
marketing approval of category I novel products.
(2) Managing by categorisation. We should learn from the
successful experience of other countries and manage biomanufactured products separately based on whether exogenous genes are introduced, distinguish the GMMs for
industrial use from those for agricultural application, and
introduce the concept of closed use and management of
GMMs. It is recommended that the common practices in the
US and EU should be taken as reference for establishing
assessment criteria, which adopt a simplified process for
chassis microorganisms that have been reviewed and approved, and create a list of safe chassis microorganisms.
(3) Establishing safety assessment criteria. By introducing
global advanced management experience (such as GRAS
notification system) and carrying out biosafety research, we
should establish scientific safety assessment criteria for
products manufactured by different GMMs. For example, the
successful biosafety management experience in other countries for category I and II GMFIs can be actively introduced
to China. There are also some cases for category III and IV
products, which should be actively investigated to push
China’s biomanufacturing industry to the top of the world.
Moreover, it is suggested that category V GMFIs should be
notified and exempted.
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Synthetic biology is an emerging technology with rapid
growth and a promising prospect. It helps scientists design
organisms different from those existing in the nature and
redesign existing organisms for enhanced or novel properties [33]. Synthetic biotechnology modifies target organisms
by mutating one or a few nucleotides, editing a large DNA
fragment, or introducing exogenous genes. Mutation or deletion of a limited number of nucleotides has similar effects
while increased precision compared with conventional mutagenesis. Crops modified in this way have been grown directly with no need for regulation all over the world [29], and
the same management practice should apply to microorganisms genetically edited in the same way. However, these
microorganisms are still under strict regulation in China and
EU, which brings great uncertainty for the development of
novel technologies and products.
Crops with genetic modification of large DNA fragments
should be managed differently from those developed with
common breeding techniques. The EU has required strict
approval of plants modified by synthetic biotechnology to
minimize the risks posed by cultivation of these plants in
open fields [34]. However, since microbial production is generally conducted in industrial reactors, the environmental
impact on GMMs can be effectively controlled through
standardized management. Therefore, the review and approval of microorganisms modified by synthetic biotechnology should be different from those of genetically modified
plants.
Synthetic biotechnology provides revolutionary product
solutions for food industry, such as lab-grown meat and
synthesized milk. Since 2011, Impossible Foods in the US
has introduced lab-grown pork and sausage based on plant
proteins and heme produced by yeast fermentation [35]. While
celebrating the approval of marketing lab-grown meat, supervision of these novel foods should be well prepared. For
lab-grown meat, the traditional supervision of meat processing by USDA (with focus on slaughter and processing
hygiene) does not apply, neither does the supervision of food
additives by FDA, because lab-grown meat is a complete
food. With the rapid development of technology, an increasing number of novel foods incompatible with existing management systems will emerge. The future development of

synthetic biology requires revision of existing laws or establishment of new laws, and identification of the weak points of
current risk assessment methods. In addition, it is essential to
think creatively about the potential unforeseen events that
may occur.
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